Donnachie, Ewan, Hapfelmeier, Alexander, Linde, Klaus et al. · BMJ open · 2022 · DOI
This study looked at health insurance records from nearly 400,000 people in Germany who had COVID-19 to see how many developed long COVID symptoms lasting at least 12 weeks. About 14% of COVID-19 patients received a diagnosis of post-COVID syndrome, with the most common symptoms being fatigue, breathing problems, and loss of taste or smell. These symptoms occurred much more often in COVID-19 patients compared to people who had other respiratory infections or no respiratory illness.
This large-scale, real-world study provides robust epidemiological evidence that post-COVID syndrome and ME/CFS-like symptoms (fatigue, cognitive impairment, dyspnoea) occur significantly more often after COVID-19 than after other respiratory infections, strengthening the case for infection-triggered post-viral illness. The finding that 6.7% of patients had persistent diagnoses over multiple quarters suggests a chronic disease burden requiring urgent clinical and research attention, including development of treatment guidelines and rehabilitation protocols.
This study does not establish causal mechanisms of post-COVID syndrome or prove that COVID-19 directly causes ME/CFS; it documents associations in claims data, which may reflect diagnostic coding practices rather than true disease incidence. The study cannot distinguish between patients with mild symptoms who sought care versus those with severe symptoms who did not, potentially biasing incidence estimates. It also does not determine whether post-COVID fatigue and ME/CFS are identical diseases or distinct entities.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →